Explores neuroprotective effects of polysaccharides in OGD/R-injured PC12 cells, suggesting their therapeutic potential.
In order to fully develop the economic value and promote the vigorous development of the economic crop Clematis armandii Franch. stems in Sichuan Province, a detailed, in-depth and systematic study on C. armandii stems polysaccharides (CAPs) was carried out. In this study, a highly applicable, practical and efficient stirring-assisted extraction method aimed to fully improve the polysaccharides yield was firstly optimized to liquid-to-solid ratio 40:1 mL/g, extraction temperature 85℃, extraction time 129 min, stirring speed 503 r/min, and the actual CAPs yield was 5.83 ± 0.26% (n = 5). Subsequently, three novel homogeneous polysaccharides (CAP-1, CAP-2 and CAP-3) were obtained via column chromatography for the first time. In order to fully clarify fine structure and neuroprotective effect of them, it was then studied by means of a variety of characterization techniques in systematically and explore their neuroprotective effect on OGD/R-induced PC12 cells injury. The structural characterization results demonstrated that CAP-1 (2.22 ×10 5 Da) and CAP-2 (1.86 ×10 5 Da) were very similar in glycosidic bond types, mainly with →4)- α - D -Glc p -(1→, →3)- α - D -Glc p -(1→ as the skeleton, while CAP-3 (6.89 ×10 5 Da) mainly with →3)- β - D -Gal p -(1→, →6)- β - D -Man p -(1→ as the skeleton, and they have different thermal stability and microstructure. The neuroprotective activity result suggested that CAP-3 presented a better neuroprotective effect against OGD/R-induced PC12 cells injury, mainly by alleviating oxidative stress injury, inhibiting apoptosis, and through the PI3K/Akt/GSK-3β signaling pathway. This study establishes a crucial theoretical basis to facilitate the profound development and optimal utilization of C. armandii stems polysaccharides. • Optimized stirring-assisted extraction achieves 5.45% CAPs yield with scalable industrial parameters. • First isolation of three novel polysaccharides (CAP-1, CAP-2, CAP-3) with distinct structures. • CAP-3 exhibits neuroprotective effects against OGD/R injury by reducing ROS levels in PC12 cells.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: